• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Clinical Update on MASLD.

作者信息

Zhang Grace Y, Brandman Danielle

机构信息

Division of General Internal Medicine, University of California, San Francisco.

Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, New York.

出版信息

JAMA Intern Med. 2025 Jan 1;185(1):105-107. doi: 10.1001/jamainternmed.2024.6431.

DOI:10.1001/jamainternmed.2024.6431
PMID:39585671
Abstract
摘要

相似文献

1
A Clinical Update on MASLD.非酒精性脂肪性肝病的临床进展
JAMA Intern Med. 2025 Jan 1;185(1):105-107. doi: 10.1001/jamainternmed.2024.6431.
2
Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.代谢功能障碍相关脂肪性肝病与非酒精性脂肪性肝病之间的一致性
Hepatol Res. 2024 Jun;54(6):600-605. doi: 10.1111/hepr.14011. Epub 2024 Jan 17.
3
Diagnostic performances of Fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction-associated steatotic liver disease in Asian primary care clinics.亚洲基层医疗诊所中，Fibrosis-4指数和非酒精性脂肪性肝病纤维化评分在代谢功能障碍相关脂肪性肝病中的诊断效能。
Hepatol Res. 2024 Nov;54(11):1027-1034. doi: 10.1111/hepr.14054. Epub 2024 May 4.
4
Metabolic dysfunction-associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis.代谢功能障碍相关脂肪性肝病标准可能会低估患有显著肝纤维化的瘦型女性非酒精性脂肪性肝病患者的数量。
Hepatol Res. 2024 May;54(5):429-438. doi: 10.1111/hepr.13994. Epub 2023 Dec 13.
5
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.代谢相关脂肪性肝病：新命名对美国肝病研究学会非酒精性脂肪性肝病实践指南的影响及更新。
Hepatology. 2024 May 1;79(5):1212-1219. doi: 10.1097/HEP.0000000000000670. Epub 2023 Nov 9.
6
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors.代谢功能障碍相关脂肪性肝病相关肝肿瘤的病理学与发病机制
Biomedicines. 2023 Oct 12;11(10):2761. doi: 10.3390/biomedicines11102761.
7
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases.代谢功能障碍相关脂肪性肝病（MASLD）和代谢功能障碍相关脂肪性肝炎（MASH）对心脏、肌肉和肾脏相关疾病的全身影响。
Front Cell Dev Biol. 2024 Jul 16;12:1433857. doi: 10.3389/fcell.2024.1433857. eCollection 2024.
8
Pharmacological treatment for metabolic dysfunction-associated steatotic liver disease and related disorders: Current and emerging therapeutic options.代谢功能障碍相关脂肪性肝病及相关疾病的药物治疗：当前及新兴治疗选择
Pharmacol Rev. 2025 Mar;77(2):100018. doi: 10.1016/j.pharmr.2024.100018. Epub 2024 Nov 22.
9
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD.代谢相关脂肪性肝病时代非侵入性评分和血清生物标志物在脂肪性肝病中的应用：从非酒精性脂肪性肝病到代谢相关脂肪性肝病和脂肪性肝病的综合评价。
Curr Obes Rep. 2024 Sep;13(3):510-531. doi: 10.1007/s13679-024-00574-z. Epub 2024 May 29.
10
Characterizing Nonalcoholic Fatty Liver Disease (NAFLD) in Lean Individuals at a Tertiary Care Hospital: A Cross-sectional Study.三级医疗中心医院对瘦人非酒精性脂肪性肝病（NAFLD）的特征分析：一项横断面研究
Euroasian J Hepatogastroenterol. 2024 Jul-Dec;14(2):198-204. doi: 10.5005/jp-journals-10018-1452. Epub 2024 Dec 27.

引用本文的文献

1
Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis.代谢功能障碍相关脂肪性肝病和肝纤维化中的花生四烯酸代谢
Hepatol Commun. 2025 Aug 29;9(9). doi: 10.1097/HC9.0000000000000802. eCollection 2025 Sep 1.
2
Lifestyle Intervention Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Children with Down Syndrome.生活方式干预改善唐氏综合征患儿代谢功能障碍相关脂肪性肝病
Nutrients. 2025 Jul 16;17(14):2331. doi: 10.3390/nu17142331.
3
Pharmacological Treatment of MASLD: Contemporary Treatment and Future Perspectives.
非酒精性脂肪性肝病的药物治疗：当代治疗方法与未来展望
Int J Mol Sci. 2025 Jul 7;26(13):6518. doi: 10.3390/ijms26136518.
4
Elevated red blood cell folate levels are associated with metabolic dysfunction-associated steatotic liver disease: results from NHANES 2017-2020.红细胞叶酸水平升高与代谢功能障碍相关脂肪性肝病有关：2017 - 2020年美国国家健康与营养检查调查结果
Front Physiol. 2025 Mar 20;16:1494863. doi: 10.3389/fphys.2025.1494863. eCollection 2025.